Sign inJoin waitlistJoin the waitlist

AZ

Andrew Zelenetz

Medical Director, Quality Informatics · New York Presbyterian Hospital

Credentials: · · · ·

History

Quality Informatics · New York Presbyterian Hospital
Present

Stanford University Medical Center
1987–1989
Internal Medicine
Stanford University Medical Center
1984–1987
Harvard Medical School
1980–1984

Research

The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Review · Blood · 2016 · 5,887 citations
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2018 · 1,863 citations
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2014 · 1,384 citations

Craig Moskowitz
89 papers
AN
Ariela Noy
77 papers
PH
Paul Hamlin
75 papers · 2 as a fellow
SH
Steven Horwitz
66 papers
Joachim Yahalom
64 papers
DS
David Straus
63 papers
AK
Anita Kumar
56 papers · 2 as a fellow
AM
Alison Moskowitz
51 papers · 3 as a fellow
Matthew Matasar
51 papers
CP
Carol Portlock
47 papers
Lia Palomba
46 papers
GS
Gilles Salles
45 papers

Grants

MSK SPORE in Lymphoma
National Cancer Institute · P50
Contact PI · $10.9M · Sloan-Kettering Inst Can Research
2016–2022
Molecular Diagnosis and Pathogensis of Lymphoma
National Cancer Institute · R01
Contact PI · $875.2K · Sloan-Kettering Inst Can Research
1993–1998
Modulation of Bcl-2 Expression by Class Switch Deletion
National Cancer Institute · R01
Contact PI · $451K · Sloan-Kettering Inst Can Research
1993–1997
Genes Activated in Transformation of Follicular Lymphoma
National Cancer Institute · K08
Contact PI · $193.3K · Stanford University
1988–1991

Clinical trials

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2027
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2019–2027
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Principal investigator · Terminated · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2014–2023
Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
Principal investigator · Completed · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2011–2023